Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01

FDA recall notice · announced March 18, 2020 · Mayne Pharma

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01

Reason for recall

Product Mix-Up: A foreign tablet was found in bottle.

Notes

Distribution: Distributed Nationwide in the USA
Lot/code information: Lot: FG11514 Exp. 05/2021
Quantity: 8274 100-count bottles
Status: Terminated
Products in this recall event:
- Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01 (D-0998-2020)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.